Alzamend Neuro Begins Phase II Trial for New Bipolar Disorder Treatment

Published 1 days agoALZN

Alzamend Neuro Begins Phase II Trial for New Bipolar Disorder Treatment

Alzamend Neuro has announced that it will initiate a Phase II clinical trial for AL001, its novel lithium delivery system, aimed at treating bipolar disorder (BD). The trial is set to commence in the third quarter of 2025, marking a significant step in the development of advanced treatment options for BD patients.

The trial, to be conducted at Massachusetts General Hospital, will pit AL001 against a marketed lithium carbonate product. The objective is to compare lithium blood levels and brain pharmacokinetics in patients. Preclinical studies have shown promising results, suggesting that AL001 enhances brain absorption while maintaining lower blood lithium levels, potentially reducing systemic side effects.

Alzamend Neuro CEO Stephan Jackman has highlighted the potential of AL001 to transform BD care by improving safety and brain targeting without the need for therapeutic drug monitoring. The company aims to provide a more user-friendly and effective treatment path, facilitating better patient outcomes and quality of life.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Funko Expands into Sports Collectibles Amid Strategic Shift

Funko Expands into Sports Collectibles Amid Strategic Shift

1 hours agoFNKO

Funko is making strategic moves to capture the attention of sports fans, starting with a partnership with the Women's National Basketball Association (WNBA). The company is launching its first-ever WNBA player Pop! figures, featuring famous athletes such as A’ja Wilson and Breanna Stewart. This initiative represents Funko's effort to honor the expanding influence of women's sports, as highlighted by an official announcement on their investor portal. In another significant move, Funko has also teamed up with the National Football League (NFL) to create customizable Pop! Yourself collectibles. Introduced in August 2024, these figures allow fans to personalize them with team-specific apparel, aiming to tap into the NFL's vast fan base. Funko's direct-to-consumer business has been flourishing, now representing around 25% of its total sales—a notable increase from 12% in 2022—as reported by marketwirenews.com. The company's strategies also include broadening distribution by selling wherever sports enthusiasts are found, such as stadiums and sporting goods stores. Funko is committed to a fan-centric approach, focusing on delighting core fans, attracting new audiences, and enhancing the fan experience. This approach is crucial for strengthening the company's connection with sports communities and fueling its sales growth strategy.

Jamie Dimon Raises Alarms Over U.S. Debt and Bond Market Risks

Jamie Dimon Raises Alarms Over U.S. Debt and Bond Market Risks

JPMorgan Chase CEO Jamie Dimon has issued a stark warning about the stability of the U.S. bond market in light of the country's escalating national debt. Dimon cautioned that the market could face significant trouble unless the government adopts a more sustainable fiscal approach. Highlighting the need for a strategic shift, he stressed the importance of averting a crisis by managing fiscal policies more effectively. In a related stance, Dimon has shown support for taxing carried interest, a move that aligns with former President Donald Trump's approach. He suggests that the $60 billion potentially raised from this tax adjustment should be directed towards aiding communities and families, enhancing the social impact of this policy change. Reuters reported that Dimon believes addressing these financial discrepancies could contribute meaningfully to the economy. Dimon also points to the pressing issue of the U.S. government's rising debt levels, which he warns could lead to disastrous outcomes if left unaddressed. Urging for prompt action, he advocates for tackling the fiscal deficit proactively to prevent more severe economic disruptions in the future. His statements reflect a broader concern about the sustainability of current fiscal policies and their long-term impact on the economy.

Cathie Wood’s ARK Buys More Intellia Shares Amid Positive Clinical Data

Cathie Wood’s ARK Buys More Intellia Shares Amid Positive Clinical Data

2 hours agoNTLA

Cathie Wood's ARK Investment Management has shown renewed confidence in Intellia Therapeutics by boosting its investment in the company's shares. On October 18, 2024, ARK purchased 161,792 shares of Intellia, with the transaction amounting to approximately $3.39 million. This acquisition was spread across ARK's ARKK and ARKG ETFs, Reuters reported. As of January 2025, ARK holds a substantial 12,536,386 shares of Intellia, valued at $101 million, making up 1.28% of its total portfolio. This significant investment highlights ARK's strategic focus on innovative genetic technologies. Intellia's recent positive clinical trial results, particularly for its CRISPR-based therapy NTLA-2002, have shown a 67% reduction in kallikrein levels after a single dose, indicating progress in treating hereditary angioedema. Intellia is sharpening its focus on its late-stage programs, such as NTLA-2002 and nexiguran ziclumeran for transthyretin amyloidosis. These initiatives are projected to offer significant value in the near term, reflecting the company's commitment to advancing gene-editing therapies that could transform the healthcare landscape. ARK's investment increase underscores its belief in Intellia's potential for impactful financial and healthcare outcomes.

Boeing's Vulcan Centaur Rocket Cleared for National Security Launches

Boeing's Vulcan Centaur Rocket Cleared for National Security Launches

Boeing's collaboration with Lockheed Martin through United Launch Alliance (ULA) reached a significant milestone in March 2025, when the U.S. Space Force certified the Vulcan Centaur rocket for launching national security satellites. This certification is a key achievement for ULA as it enhances its profile in the competitive aerospace market dominated by rivals like SpaceX. The certification followed the successful second mission of the Vulcan Centaur in October 2024, an essential step in fulfilling the requirements needed for Pentagon missions, as reported by Reuters. ULA is ramping up its operations with plans to carry out 12 launches in 2025. Moreover, the company aims to double this number in 2026. This aggressive launch schedule is part of a strategy to bolster its presence in the rapidly expanding market for satellite launches, particularly in competition with SpaceX's Falcon 9. ULA's efforts to capture a larger share of the commercial satellite market reflect its ambition to become a key player in the low Earth orbit sector. In a strategic move, Boeing and Lockheed Martin entered discussions in August 2024 to potentially sell ULA to Sierra Space, with a valuation between $2 to $3 billion. This potential sale indicates a shift in Boeing's approach to its space operations, opening new avenues for expansion and partnerships. By positioning Vulcan Centaur to meet both national security and commercial needs, Boeing and ULA continue to adapt in the evolving space industry landscape.